Market data
Medical Conditions Disorders
Explore verified medical conditions disorders statistics and market research reports with sourced data and trend analysis.
Latest update:


Inflammatory Breast Cancer Statistics
Inflammatory breast cancer is rare yet aggressive, making up about 1% to 5% of breast cancers, diagnosed at a median age of 53 and often recurring fast with a median time to first recurrence of 14 months versus 22 months for non inflammatory disease. This page pulls together the most urgent statistics, from the roughly 6 cm typical tumor size and high rates of grade 3 and lymphatic invasion to treatment impact where multimodality care can lift survival and neoadjuvant HER2 targeted therapy can drive 50% pathologic complete response in HER2 positive IBC.

Worldwide Diabetes Statistics
Diabetes is costing far more than medicines, with global estimates putting the economic and health burden from direct costs to DALYs in the same spotlight as WHO warnings that early diagnosis can prevent or delay complications. The page also contrasts massive gaps in access and outcomes with the guidance behind modern care, from ADA targets like A1C under 7% for many adults to fast changing technology markets including insulin and CGM growth projections and the year to year expansion of GLP 1 and SGLT2 adoption and research.

Spina Bifida Statistics
With up to 70% of children eventually needing a shunt for hydrocephalus and about 25% to 40% using a wheelchair at some point, this page maps the lifelong medical ripple effects of spina bifida. You will also see how prenatal prevention and care choices collide with outcomes, from folic acid timing and scan detection to the cost drivers that add up to billions in the US.

Chicken Pox Statistics
Even with vaccination, chickenpox still packs a punch, from bacterial skin infections in 5 to 10% of cases to varicella pneumonia in 1 in 400 adults that carries a 10 to 30% mortality risk. You can also see why timing matters, with virus shedding peaking 1 to 2 days before the rash and the contagious period lasting until all lesions crust, plus how two-dose vaccination after 1995 slashed US cases by 87% between 1995 and 2000.

Breast Cancer Survival Rate Statistics
Get a clear, up-to-date picture of breast cancer survival using the newest US 2014 to 2020 benchmarks, where the overall 5 year relative survival is 91.4% and key gaps by age, race, stage, and subtype quickly become visible. You will see how survival can run from 99.3% for localized disease down to 31.2% for distant metastatic cancer, with striking differences for groups like US Black women (81.7%) and triple negative breast cancer that drops sharply when it reaches metastatic HER2 positive levels.

Metastatic Colorectal Cancer Statistics
A stage IV diagnosis is often already visible on CT or MRI with liver metastases and rising CEA where 75% of metastatic colorectal cancer is detected this way and liver is the primary site in 65%, yet the newest imaging and biomarkers can still change the plan in 20 to 30%. From ctDNA and liquid biopsy signals that flag recurrence up to 87% sensitivity to targeted mutation testing and treatment outcomes, this page connects detection accuracy with what it means for survival right now.

Opioid Use Disorder Statistics
Nearly 3.7 million people aged 12 and older had opioid use disorder in 2022, yet only 29.6% of those who received treatment got medications for opioid use disorder, even as waiting lists and affordability barriers persist. The page also tracks how MOUD prescriber access, retention, overdose reductions, and even naloxone and fentanyl trends move together, including about 98,000 clinicians able to prescribe buprenorphine in 2023.

Tetanus Statistics
Even in 2019 tetanus still killed about 49,000 people worldwide, and 92% of those deaths occurred in low and lower middle income countries, despite vaccine protection that can be lifelong after 3 doses. The page also tracks how neonatal tetanus fell from 787,000 deaths in 1990 to under 10,000 by 2020, while showing what first signs like jaw locking and grimacing reveal about severe generalized cases and the ICU care they often need.

Copd Age Statistics
COPD trends are moving in the right direction yet the burden stays stubborn, with the global age standardized death rate falling 3.3% per year on average from 2000 to 2019 while about 3.2% of adults aged 45 plus live with COPD worldwide. You will also see why risk is still driven by smoking and exposures, alongside treatment and prevention clues such as triple therapy cutting exacerbations and pulmonary rehabilitation boosting 6 minute walk distance by roughly 40 to 50 meters.

Diabetes Amputation Statistics
Diabetes amputations carry a staggering toll with 5 year mortality after the first amputation rising as high as 68 percent and a 50 percent one year readmission rate, mostly driven by infections. Yet the same page shows prevention can work fast, with foot screening cutting amputation rates by 85 percent and multidisciplinary foot teams halving major amputations, alongside the scale of the burden in the US where roughly 140,000 lower limb amputations occur each year.

Chickenpox Statistics
Even though chickenpox looks like a mild childhood rash, the page pairs 2021 US vaccination coverage with hard risks like varicella pneumonia in 1 in 400 adults and encephalitis in 1 in 33,000 children, then shows how vaccination cut US cases from about 4 million a year to roughly 150,000 to 200,000. You will also see how fast contagion peaks, why scratching can drive bacterial superinfection, and what it means for households where the secondary attack rate can hit 87%.

Hiv Gender Statistics
In 2023, 86% of people living with HIV knew their status, but women were consistently ahead at 92% versus 80% for men, while treatment and viral suppression still show stubborn gaps. Pair that with the 2022 picture of who is newly infected and who is dying, including women making up 1.3 million new infections and accounting for 43% of AIDS related deaths, and you get a clear view of where gender shaped outcomes most.

Pulmonary Embolism Statistics
Follow-up imaging does not reassure as much as you might expect after a first pulmonary embolism, with 65% showing persistent pulmonary perfusion defects, while 30-day mortality still ranges from 2.4% in a large registry to 5.6% in RIETE. This page maps the full risk arc from chronic thromboembolic pulmonary hypertension and right ventricular dysfunction to recurrence and treatment tradeoffs, including D-dimer based safety for ruling out PE with about a 1% failure rate.

Gallbladder Cancer Statistics
See how gallbladder cancer outcomes split by stage in SEER and why the survival gap is stark, from 67.1% localized to just 8.6% distant for 2009–2015. Then connect risk you can measure to causes you can act on, from gallstones in 75% of cases and gallbladder polyps at 37% risk when they reach 10 mm, to modern trial results such as durvalumab plus gemcitabine and cisplatin improving overall survival with a reported hazard ratio of 0.76.

Melanoma Recurrence Statistics
Five years after treatment, 39% of stage I to II melanoma patients go on to relapse or another event, and the most common distant pattern includes central nervous system involvement. This page ties that reality to measurable risk drivers like thickness, AJCC stage IV, node positivity, and modern surveillance tools such as PET CT and ctDNA, including how ctDNA can flag recurrence earlier than conventional imaging.

Dvt Death Statistics
Dvt Death lays out why preventable decisions change outcomes fast, from anticoagulants cutting DVT mortality by 60% to LMWH prophylaxis reducing hospital VTE deaths by 40%, and why untreated proximal DVT can turn fatal. You will also see the newest national baseline for 2019 PE mortality at 9.5 per 100,000 and how risk surges with obesity, smoking, oral contraceptives, and immobility longer than 3 days.

Diabetes Uk Statistics
With 4.4 million people in the UK living with diabetes in 2023 and cardiovascular disease twice as common among them, this Diabetes UK statistics page shows where care and prevention are still falling short. From 10,000 diabetes related amputations every year to 32% getting all 9 recommended checks and 150 research projects funded in 2022 to 2023, it captures both the scale of the challenge and the concrete changes Diabetes UK has helped drive.

Neurodiversity Statistics
From late diagnoses to missed early screening, these 2023 backed neurodiversity statistics reveal how school timelines shape outcomes. You will see why 65% of neurodivergent students leave higher education and how autism, ADHD, and dyslexia can link to lower grades, poorer employment prospects, and even higher health risk.

Childhood Acute Lymphoblastic Leukemia Statistics
HSCT and CAR T therapy can deliver long-term control in selected pediatric and young adult B-ALL cases, yet the page shows why MRD measurement is the real turning point, including 3 year event free survival of 90% for AALL0431 patients reaching MRD below 0.01% and a pooled relapse hazard ratio of about 5 for MRD positive versus MRD negative. It also connects next generation testing sensitivity down to roughly 10−6 with practical outcomes such as frequent infections during induction therapy and the late effects survivors face, so you can see where today’s remission estimates meet real long term risk.

Lupus Life Expectancy Statistics
From hydroxychloroquine linked to improved survival to infections striking about 15 percent of people with lupus in a 1 year span, this page turns scattered findings into a clear, current picture of what most drives lupus life expectancy. You will also see how deprivation, missed monitoring, and organ damage progression can widen the gap between “lower risk” and “high-risk” outcomes.